These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Possible Application of Melatonin in Long COVID. Cardinali DP; Brown GM; Pandi-Perumal SR Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358996 [TBL] [Abstract][Full Text] [Related]
26. Chronic fatigue syndrome and cognitive deficit are associated with acute-phase neuropsychiatric manifestations of COVID-19: A 9-month follow-up study. Mirfazeli FS; Sarabi-Jamab A; Pereira-Sanchez V; Kordi A; Shariati B; Shariat SV; Bahrami S; Nohesara S; Almasi-Dooghaee M; Faiz SHR Neurol Sci; 2022 Apr; 43(4):2231-2239. PubMed ID: 35059902 [TBL] [Abstract][Full Text] [Related]
27. Female gender is associated with long COVID syndrome: a prospective cohort study. Bai F; Tomasoni D; Falcinella C; Barbanotti D; Castoldi R; Mulè G; Augello M; Mondatore D; Allegrini M; Cona A; Tesoro D; Tagliaferri G; Viganò O; Suardi E; Tincati C; Beringheli T; Varisco B; Battistini CL; Piscopo K; Vegni E; Tavelli A; Terzoni S; Marchetti G; Monforte AD Clin Microbiol Infect; 2022 Apr; 28(4):611.e9-611.e16. PubMed ID: 34763058 [TBL] [Abstract][Full Text] [Related]
28. Response to letter to the editor regarding "Multi-Disciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in patients with Post-Acute sequelae of SARS-CoV-2 infection (PASC)". Herrera JE; Niehaus WN; Whiteson J; Azola A; Baratta JM; Fleming TK; Kim SY; Naqvi H; Sampsel S; Silver JK; Verduzco-Gutierrez M; Maley JH; Herman E; Abramoff B PM R; 2021 Dec; 13(12):1439-1440. PubMed ID: 34617402 [No Abstract] [Full Text] [Related]
29. Post-acute sequelae of SARS-CoV-2 infection: relationship of central nervous system manifestations with physical disability and systemic inflammation. Busatto GF; de Araujo AL; Castaldelli-Maia JM; Damiano RF; Imamura M; Guedes BF; de Rezende Pinna F; Sawamura MVY; Mancini MC; da Silva KR; Garcia ML; Sumita N; Brunoni AR; da Silva Duarte AJ; Burdmann EA; Kallas EG; Cerri GG; Nitrini R; Bento RF; Rocha VG; de Souza HP; Miguel EC; de Carvalho CRR; Forlenza OV; Batistella LR; Psychol Med; 2022 Sep; 52(12):2387-2398. PubMed ID: 35521752 [TBL] [Abstract][Full Text] [Related]
30. Late-Onset Hypogonadism in a Male Patient with Long COVID Diagnosed by Exclusion of ME/CFS. Soejima Y; Otsuka Y; Tokumasu K; Nakano Y; Harada K; Nakamoto K; Sunada N; Sakurada Y; Hasegawa K; Hagiya H; Ueda K; Otsuka F Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454374 [TBL] [Abstract][Full Text] [Related]
31. [Fatigue at Long COVID]. Weingärtner AL; Stengel A Psychother Psychosom Med Psychol; 2021 Dec; 71(12):515-527. PubMed ID: 34872154 [TBL] [Abstract][Full Text] [Related]
32. Long COVID syndrome: An unfolding enigma. Sharma SK; Mohan A; Upadhyay V Indian J Med Res; 2024 Jun; 159(6):585-600. PubMed ID: 39382470 [TBL] [Abstract][Full Text] [Related]
33. The Relationship between Post-COVID Syndrome and the Burden of Comorbidities Assessed Using the Charlson Comorbidity Index. Falsetti L; Zaccone V; Santoro L; Santini S; Guerrieri E; Giuliani L; Viticchi G; Cataldi S; Gasbarrini A; Landi F; Santoliquido A; Moroncini G; On Behalf Of Gemelli Against Covid-Post-Acute Care Study Group Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763702 [No Abstract] [Full Text] [Related]
34. [Long COVID: Is it really myalgic encephalomyelitis? Bibliographic review and considerations]. Espinosa Rodríguez P; Martínez Aguilar A; Ripoll Muñoz MP; Rodríguez Navarro MÁ Semergen; 2022; 48(1):63-69. PubMed ID: 34531126 [TBL] [Abstract][Full Text] [Related]
36. The Importance of Listening in Treating Invisible Illness and Long-Haul COVID-19. Wall D AMA J Ethics; 2021 Jul; 23(7):E590-595. PubMed ID: 34351274 [TBL] [Abstract][Full Text] [Related]
37. Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes. Spinicci M; Graziani L; Tilli M; Nkurunziza J; Vellere I; Borchi B; Mencarini J; Campolmi I; Gori L; Giovannoni L; Amato C; Livi L; Rasero L; Fattirolli F; Marcucci R; Giusti B; Olivotto I; Tomassetti S; Lavorini F; Maggi L; Annunziato F; Marchionni N; Zammarchi L; Bartoloni A Viruses; 2022 Oct; 14(11):. PubMed ID: 36366465 [TBL] [Abstract][Full Text] [Related]
38. Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection. Vu QM; Fitzpatrick AL; Cope JR; Bertolli J; Sotoodehnia N; West TE; Gentile N; Unger ER Emerg Infect Dis; 2024 Mar; 30(3):539-547. PubMed ID: 38407166 [TBL] [Abstract][Full Text] [Related]
39. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome. Apostolou E; Rizwan M; Moustardas P; Sjögren P; Bertilson BC; Bragée B; Polo O; Rosén A Front Immunol; 2022; 13():949787. PubMed ID: 36341457 [TBL] [Abstract][Full Text] [Related]
40. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]